down arrow

Natco Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE987B01026
  • NSEID: NATCOPHARM
  • BSEID: 524816
  • View on NSE | View on BSE
INR
849.10
11.25 (1.34%)
BSENSE

Sep 24, 11:30 AM

BSE+NSE Vol: 3.42 lacs

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
35.80
35.80
35.80
36.50
36.50
36.50
Share Warrants & Outstandings
Total Reserve
9,185.30
7,571.20
5,817.30
4,837.30
4,223.70
4,067.60
Shareholder's Funds
9,221.10
7,607.00
5,853.10
4,873.80
4,263.60
4,121.60
Minority Interest
0.00
5.30
0.00
0.00
0.00
1.80
Long-Term Borrowings
100.00
0.00
0.00
0.00
0.00
0.90
Secured Loans
100.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.90
Deferred Tax Assets / Liabilities
-232.40
-49.90
-19.20
12.40
30.10
41.30
Other Long Term Liabilities
9.7
9.2
9.3
2.8
9.3
1.1
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
61.80
65.60
70.90
85.30
95.70
99.60
Total Non-Current Liabilities
-60.90
24.90
61.00
100.50
135.10
142.90
Current Liabilities
Trade Payables
409.30
274.90
235.50
263.80
161.80
146.20
Other Current Liabilities
315.00
317.60
271.20
237.40
127.60
99.90
Short Term Borrowings
606.40
273.10
363.20
165.00
404.00
266.70
Short Term Provisions
350.20
77.90
102.90
16.90
17.00
12.80
Total Current Liabilities
1,680.90
943.50
972.80
683.10
710.40
525.60
Total Liabilities
10,841.10
8,580.70
6,886.90
5,657.40
5,109.10
4,791.90
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
4,256.50
4,016.10
3,603.20
3,375.10
3,126.90
2,702.10
Less: Accumulated Depreciation
1,403.80
1,267.80
1,112.40
948.20
815.10
678.90
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
2,802.70
2,698.00
2,490.80
2,426.90
2,311.80
2,023.20
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
293.70
225.40
137.30
64.30
129.50
223.40
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
2,548.90
152.80
95.90
87.30
104.40
159.40
Long Term Loans & Advances
103.40
77.80
114.00
78.30
73.00
45.10
Other Non Current Assets
40.10
156.70
25.40
0.30
3.70
3.50
Total Non-Current Assets
5,788.80
3,310.70
2,863.40
2,657.10
2,622.40
2,454.60
Current Assets Loans & Advances
Current Investments
578.20
320.80
443.50
305.00
203.70
144.30
Inventories
908.50
765.80
700.50
742.90
762.00
798.20
Sundry Debtors
881.20
1,246.60
1,188.90
856.10
620.60
412.90
Cash and Bank
1,550.90
2,176.00
952.90
546.30
206.10
283.50
Other Current Assets
102.40
135.10
99.50
63.40
88.10
94.70
Short Term Loans and Advances
1,031.10
625.70
638.20
486.60
606.20
603.70
Total Current Assets
5,052.30
5,270.00
4,023.50
3,000.30
2,486.70
2,337.30
Net Current Assets (Including Current Investments)
3,371.40
4,326.50
3,050.70
2,317.20
1,776.30
1,811.70
Total Current Assets Excluding Current Investments
4,474.10
4,949.20
3,580.00
2,695.30
2,283.00
2,193.00
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
10,841.10
8,580.70
6,886.90
5,657.40
5,109.10
4,791.90
Contingent Liabilities
3.00
3.00
0.40
14.60
8.00
1.20
Total Debt
706.40
273.10
363.20
165.00
404.00
267.60
Book Value per share (adjusted)
0
424.97
326.99
267.06
233.62
225.84
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 158.66% vs -24.81% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 5.43% vs -1.08% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 5.92% vs 11.24% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 1,568.13% vs 59.33% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is -4.13% vs 30.98% in Mar 2025

Compare Balance Sheet Results of Natco Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
35.80
45.32
-9.52
-21.01%
Share Warrants & Outstandings
Total Reserve
9,185.30
2,977.84
6,207.46
208.46%
Shareholder's Funds
9,221.10
3,023.16
6,197.94
205.02%
Minority Interest
0.00
29.52
-29.52
-100.00%
Long-Term Borrowings
100.00
0.00
100.00
0.00%
Secured Loans
100.00
0.00
100.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-232.40
-7.88
-224.52
-2,849.24%
Other Long Term Liabilities
9.70
270.13
-260.43
-96.41%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
61.80
5.92
55.88
943.92%
Total Non-Current Liabilities
-60.90
268.17
-329.07
-122.71%
Current Liabilities
Trade Payables
409.30
336.91
72.39
21.49%
Other Current Liabilities
315.00
160.27
154.73
96.54%
Short Term Borrowings
606.40
29.59
576.81
1,949.34%
Short Term Provisions
350.20
0.32
349.88
109,337.50%
Total Current Liabilities
1,680.90
527.09
1,153.81
218.90%
Total Liabilities
10,841.10
3,847.94
6,993.16
181.74%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
4,256.50
1,193.51
3,062.99
256.64%
Less: Accumulated Depreciation
1,403.80
450.28
953.52
211.76%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2,802.70
743.24
2,059.46
277.09%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
293.70
14.78
278.92
1,887.14%
Intangible assets under development
0.00
43.80
-43.80
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2,548.90
0.00
2,548.90
0.00%
Long Term Loans & Advances
103.40
22.50
80.90
359.56%
Other Non Current Assets
40.10
0.01
40.09
400,900.00%
Total Non-Current Assets
5,788.80
1,125.20
4,663.60
414.47%
Current Assets Loans & Advances
Current Investments
578.20
0.00
578.20
0.00%
Inventories
908.50
972.28
-63.78
-6.56%
Sundry Debtors
881.20
644.57
236.63
36.71%
Cash and Bank
1,550.90
989.65
561.25
56.71%
Other Current Assets
102.40
51.05
51.35
100.59%
Short Term Loans and Advances
1,031.10
65.19
965.91
1,481.68%
Total Current Assets
5,052.30
2,722.74
2,329.56
85.56%
Net Current Assets (Including Current Investments)
3,371.40
2,195.65
1,175.75
53.55%
Total Current Assets Excluding Current Investments
4,474.10
2,722.74
1,751.36
64.32%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
10,841.10
3,847.94
6,993.16
181.74%
Contingent Liabilities
3.00
0.00
3.00
0.00%
Total Debt
706.40
29.59
676.81
2,287.29%
Book Value per share (adjusted)
0.00
66.71
-66.71
-100.00%
Annual - Borrowings
Borrowings 706.40 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 158.66% vs -24.81% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 9.70 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 5.43% vs -1.08% in Mar 2025

Annual - Fixed Assets
Fixed Assets 3,096.40 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 5.92% vs 11.24% in Mar 2025

Annual - Investments
Investments 2,548.90 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 1,568.13% vs 59.33% in Mar 2025

Annual - Current Assets
Current Assets 5,052.30 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -4.13% vs 30.98% in Mar 2025

Footer loading